论文部分内容阅读
目的观察尿激酶溶栓疗法治疗脑血栓的效果。方法将脑血栓患者90例采用电脑随机分组方式分为研究组与常规组,每组45例。常规组给予常规治疗,研究组给予尿激酶溶栓疗法,对比2组患者临床疗效和不良反应发生情况。结果研究组总有效率为93.33%高于常规组的68.89%,差异有统计学意义(P<0.05);2组不良反应发生率比较差异无统计学意义(P>0.05)。结论尿激酶溶栓疗法治疗脑血栓效果显著,不会对患者身体造成较大的伤害,安全可靠,具有较高的临床应用价值。
Objective To observe the effect of urokinase thrombolytic therapy on cerebral thrombosis. Methods Ninety patients with cerebral thrombosis were randomly divided into study group and conventional group with 45 cases in each group. The conventional group was given routine treatment, and the study group was given urokinase thrombolytic therapy, comparing the clinical efficacy and adverse reactions in the two groups. Results The total effective rate was 93.33% in the study group, which was significantly higher than that in the conventional group (68.89%, P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusions Urokinase thrombolytic therapy is effective in treating cerebral thrombosis and will not cause great harm to the patient’s body, which is safe and reliable and has high clinical value.